ProMIS™ Neurosciences, Inc. is a development-stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).

Biotechnology

ProMIS Neurosciences

Elliot Goldstein

Ernest D. Bush

Johanne Kaplan

Daniel Geffken

Neil Cashman

Gavin T. Malenfant

Dennis Chen

Michael Grundman

David Wishart

Larry Altstiel

Scientific Research Team

Finance and Administration

Leadership Team

��

Teams at ProMIS Neurosciences

Scientific Research Team

Finance and Administration

Leadership Team

��������

Teams at ProMIS Neurosciences

Scientific Research Team

Finance and Administration

Leadership Team

��